|
Primary outcome measures for the treatment groups after 12 months |
|||
| Primary outcome measures |
Surgery (n = 73) |
Splint (n = 83) |
Difference* |
|
|
|||
| Success rate (%)** |
92% (67/73) |
72% (60/83) |
20% (8; 31) |
| # nights waking up due to complaints (0–7)** |
3.6 (2.9) |
2.9 (3.0) |
0.7 (-0.2; 1.7) |
| Severity of the main complaint (0–10)** |
6.4 (2.7) |
5.1 (3.1) |
1.3 (0.4; 2.2) |
| Paraesthesia during the day (0–10)** |
5.5 (2.9) |
4.0 (3.4) |
1.5 (0.5; 2.5) |
| Paraesthesia at night (0–10)** |
5.2 (3.6) |
4.5 (3.4) |
0.7 (-0.4; 1.8) |
| Utility (EuroQol; 0–1)*** |
0.85 (0.12) |
0.81 (0.16) |
0.04 (-0.004; 0.08) |
|
*Presented are the difference in success rate and the differences in the mean improvements from baseline (95% confidence interval); **Presented are the success rate and the mean (standard deviation) improvements from baseline; ***Utility is scored for one year. | |||
Korthals-de Bos et al. BMC Musculoskeletal Disorders 2006 7:86 doi:10.1186/1471-2474-7-86 |
|||